nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—CYP2C8—Dapsone—systemic lupus erythematosus	0.0437	0.086	CbGbCtD
Paroxetine—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0428	0.0842	CbGbCtD
Paroxetine—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.0379	0.0745	CbGbCtD
Paroxetine—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0338	0.0666	CbGbCtD
Paroxetine—CYP2C9—Dapsone—systemic lupus erythematosus	0.0305	0.06	CbGbCtD
Paroxetine—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.0304	0.0598	CbGbCtD
Paroxetine—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.0287	0.0565	CbGbCtD
Paroxetine—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0256	0.0505	CbGbCtD
Paroxetine—CYP2B6—Dexamethasone—systemic lupus erythematosus	0.025	0.0491	CbGbCtD
Paroxetine—ABCB1—Betamethasone—systemic lupus erythematosus	0.022	0.0433	CbGbCtD
Paroxetine—ABCB1—Prednisolone—systemic lupus erythematosus	0.0217	0.0427	CbGbCtD
Paroxetine—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0206	0.0405	CbGbCtD
Paroxetine—ABCB1—Prednisone—systemic lupus erythematosus	0.0205	0.0403	CbGbCtD
Paroxetine—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.02	0.0394	CbGbCtD
Paroxetine—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0194	0.0382	CbGbCtD
Paroxetine—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.0189	0.0372	CbGbCtD
Paroxetine—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.0183	0.036	CbGbCtD
Paroxetine—CYP2C9—cardial valve—systemic lupus erythematosus	0.0136	0.17	CbGeAlD
Paroxetine—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.0132	0.0259	CbGbCtD
Paroxetine—ABCB1—Dexamethasone—systemic lupus erythematosus	0.0128	0.0252	CbGbCtD
Paroxetine—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.0121	0.0237	CbGbCtD
Paroxetine—ABCB1—Methotrexate—systemic lupus erythematosus	0.0103	0.0202	CbGbCtD
Paroxetine—HTR2A—choroid plexus—systemic lupus erythematosus	0.009	0.113	CbGeAlD
Paroxetine—CYP2C9—urine—systemic lupus erythematosus	0.00293	0.0366	CbGeAlD
Paroxetine—TACR1—connective tissue—systemic lupus erythematosus	0.00274	0.0343	CbGeAlD
Paroxetine—HTR2A—urine—systemic lupus erythematosus	0.00241	0.0301	CbGeAlD
Paroxetine—SLC6A4—blood plasma—systemic lupus erythematosus	0.00238	0.0297	CbGeAlD
Paroxetine—CYP2D6—urine—systemic lupus erythematosus	0.00219	0.0274	CbGeAlD
Paroxetine—CHRM5—skin of body—systemic lupus erythematosus	0.00182	0.0228	CbGeAlD
Paroxetine—CYP2C8—blood plasma—systemic lupus erythematosus	0.00172	0.0215	CbGeAlD
Paroxetine—TACR1—lung—systemic lupus erythematosus	0.00166	0.0207	CbGeAlD
Paroxetine—CYP2B6—blood plasma—systemic lupus erythematosus	0.00154	0.0193	CbGeAlD
Paroxetine—TACR1—nervous system—systemic lupus erythematosus	0.00153	0.0192	CbGeAlD
Paroxetine—CYP2C9—blood plasma—systemic lupus erythematosus	0.00153	0.0191	CbGeAlD
Paroxetine—TACR1—central nervous system—systemic lupus erythematosus	0.00148	0.0185	CbGeAlD
Paroxetine—CHRM4—nervous system—systemic lupus erythematosus	0.00144	0.018	CbGeAlD
Paroxetine—HTR2A—endothelium—systemic lupus erythematosus	0.00142	0.0177	CbGeAlD
Paroxetine—CHRM4—central nervous system—systemic lupus erythematosus	0.00139	0.0174	CbGeAlD
Paroxetine—HTR2A—blood plasma—systemic lupus erythematosus	0.00126	0.0157	CbGeAlD
Paroxetine—CYP2D6—blood plasma—systemic lupus erythematosus	0.00115	0.0143	CbGeAlD
Paroxetine—CHRM5—nervous system—systemic lupus erythematosus	0.00113	0.0141	CbGeAlD
Paroxetine—CHRM5—central nervous system—systemic lupus erythematosus	0.00108	0.0136	CbGeAlD
Paroxetine—CHRM3—kidney—systemic lupus erythematosus	0.00096	0.012	CbGeAlD
Paroxetine—SLC6A3—lung—systemic lupus erythematosus	0.000833	0.0104	CbGeAlD
Paroxetine—ABCB1—blood plasma—systemic lupus erythematosus	0.000824	0.0103	CbGeAlD
Paroxetine—CYP2B6—nephron tubule—systemic lupus erythematosus	0.000795	0.00994	CbGeAlD
Paroxetine—CYP2C8—kidney—systemic lupus erythematosus	0.000779	0.00974	CbGeAlD
Paroxetine—CHRM2—nervous system—systemic lupus erythematosus	0.000773	0.00967	CbGeAlD
Paroxetine—SLC6A3—nervous system—systemic lupus erythematosus	0.000771	0.00964	CbGeAlD
Paroxetine—SLC6A4—lung—systemic lupus erythematosus	0.000763	0.00954	CbGeAlD
Paroxetine—CHRM1—lung—systemic lupus erythematosus	0.00076	0.00951	CbGeAlD
Paroxetine—CHRM2—central nervous system—systemic lupus erythematosus	0.000745	0.00931	CbGeAlD
Paroxetine—SLC6A3—central nervous system—systemic lupus erythematosus	0.000742	0.00928	CbGeAlD
Paroxetine—CYP2B6—skin of body—systemic lupus erythematosus	0.000741	0.00927	CbGeAlD
Paroxetine—SLC6A4—nervous system—systemic lupus erythematosus	0.000707	0.00884	CbGeAlD
Paroxetine—CHRM1—nervous system—systemic lupus erythematosus	0.000704	0.0088	CbGeAlD
Paroxetine—CYP2B6—kidney—systemic lupus erythematosus	0.000699	0.00874	CbGeAlD
Paroxetine—SLC6A4—central nervous system—systemic lupus erythematosus	0.00068	0.00851	CbGeAlD
Paroxetine—CHRM1—central nervous system—systemic lupus erythematosus	0.000678	0.00847	CbGeAlD
Paroxetine—SLC6A2—lung—systemic lupus erythematosus	0.000672	0.0084	CbGeAlD
Paroxetine—HTR2A—connective tissue—systemic lupus erythematosus	0.000669	0.00837	CbGeAlD
Paroxetine—CHRM3—nervous system—systemic lupus erythematosus	0.00063	0.00788	CbGeAlD
Paroxetine—SLC6A2—nervous system—systemic lupus erythematosus	0.000622	0.00778	CbGeAlD
Paroxetine—CHRM3—central nervous system—systemic lupus erythematosus	0.000607	0.00758	CbGeAlD
Paroxetine—CYP2B6—lymphoid tissue—systemic lupus erythematosus	0.0006	0.0075	CbGeAlD
Paroxetine—SLC6A2—central nervous system—systemic lupus erythematosus	0.000599	0.00749	CbGeAlD
Paroxetine—HTR2A—kidney—systemic lupus erythematosus	0.00057	0.00713	CbGeAlD
Paroxetine—CYP2D6—kidney—systemic lupus erythematosus	0.000519	0.00649	CbGeAlD
Paroxetine—CYP2B6—lung—systemic lupus erythematosus	0.000495	0.00619	CbGeAlD
Paroxetine—HTR2A—tendon—systemic lupus erythematosus	0.00046	0.00575	CbGeAlD
Paroxetine—CYP2B6—nervous system—systemic lupus erythematosus	0.000458	0.00573	CbGeAlD
Paroxetine—CYP2B6—central nervous system—systemic lupus erythematosus	0.000441	0.00552	CbGeAlD
Paroxetine—ABCB1—nephron tubule—systemic lupus erythematosus	0.000425	0.00531	CbGeAlD
Paroxetine—HTR2A—lung—systemic lupus erythematosus	0.000404	0.00505	CbGeAlD
Paroxetine—HTR2A—nervous system—systemic lupus erythematosus	0.000374	0.00468	CbGeAlD
Paroxetine—ABCB1—kidney—systemic lupus erythematosus	0.000373	0.00467	CbGeAlD
Paroxetine—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000364	0.00455	CbGeAlD
Paroxetine—HTR2A—central nervous system—systemic lupus erythematosus	0.00036	0.0045	CbGeAlD
Paroxetine—CYP2D6—nervous system—systemic lupus erythematosus	0.000341	0.00426	CbGeAlD
Paroxetine—CYP2D6—central nervous system—systemic lupus erythematosus	0.000328	0.0041	CbGeAlD
Paroxetine—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000321	0.00401	CbGeAlD
Paroxetine—ABCB1—bone marrow—systemic lupus erythematosus	0.000292	0.00365	CbGeAlD
Paroxetine—ABCB1—lung—systemic lupus erythematosus	0.000265	0.00331	CbGeAlD
Paroxetine—ABCB1—nervous system—systemic lupus erythematosus	0.000245	0.00306	CbGeAlD
Paroxetine—ABCB1—central nervous system—systemic lupus erythematosus	0.000236	0.00295	CbGeAlD
Paroxetine—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	7.34e-05	0.000193	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	7.32e-05	0.000192	CcSEcCtD
Paroxetine—Pain—Hydrocortisone—systemic lupus erythematosus	7.31e-05	0.000192	CcSEcCtD
Paroxetine—Oedema—Betamethasone—systemic lupus erythematosus	7.31e-05	0.000192	CcSEcCtD
Paroxetine—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	7.31e-05	0.000192	CcSEcCtD
Paroxetine—Oedema—Dexamethasone—systemic lupus erythematosus	7.31e-05	0.000192	CcSEcCtD
Paroxetine—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	7.31e-05	0.000192	CcSEcCtD
Paroxetine—Insomnia—Triamcinolone—systemic lupus erythematosus	7.28e-05	0.000191	CcSEcCtD
Paroxetine—Insomnia—Methylprednisolone—systemic lupus erythematosus	7.27e-05	0.000191	CcSEcCtD
Paroxetine—Infection—Betamethasone—systemic lupus erythematosus	7.26e-05	0.000191	CcSEcCtD
Paroxetine—Infection—Dexamethasone—systemic lupus erythematosus	7.26e-05	0.000191	CcSEcCtD
Paroxetine—Ill-defined disorder—Prednisone—systemic lupus erythematosus	7.24e-05	0.00019	CcSEcCtD
Paroxetine—Paraesthesia—Triamcinolone—systemic lupus erythematosus	7.23e-05	0.00019	CcSEcCtD
Paroxetine—Feeling abnormal—Prednisolone—systemic lupus erythematosus	7.22e-05	0.00019	CcSEcCtD
Paroxetine—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	7.22e-05	0.00019	CcSEcCtD
Paroxetine—Visual impairment—Methotrexate—systemic lupus erythematosus	7.21e-05	0.00019	CcSEcCtD
Paroxetine—Anaemia—Prednisone—systemic lupus erythematosus	7.21e-05	0.000189	CcSEcCtD
Paroxetine—Shock—Betamethasone—systemic lupus erythematosus	7.19e-05	0.000189	CcSEcCtD
Paroxetine—Shock—Dexamethasone—systemic lupus erythematosus	7.19e-05	0.000189	CcSEcCtD
Paroxetine—Dyspnoea—Triamcinolone—systemic lupus erythematosus	7.18e-05	0.000189	CcSEcCtD
Paroxetine—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	7.17e-05	0.000188	CcSEcCtD
Paroxetine—Nervous system disorder—Betamethasone—systemic lupus erythematosus	7.17e-05	0.000188	CcSEcCtD
Paroxetine—Agitation—Prednisone—systemic lupus erythematosus	7.17e-05	0.000188	CcSEcCtD
Paroxetine—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	7.16e-05	0.000188	CcSEcCtD
Paroxetine—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	7.16e-05	0.000188	CcSEcCtD
Paroxetine—Tachycardia—Betamethasone—systemic lupus erythematosus	7.13e-05	0.000187	CcSEcCtD
Paroxetine—Tachycardia—Dexamethasone—systemic lupus erythematosus	7.13e-05	0.000187	CcSEcCtD
Paroxetine—Angioedema—Prednisone—systemic lupus erythematosus	7.13e-05	0.000187	CcSEcCtD
Paroxetine—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	7.09e-05	0.000186	CcSEcCtD
Paroxetine—Dyspepsia—Triamcinolone—systemic lupus erythematosus	7.09e-05	0.000186	CcSEcCtD
Paroxetine—Erythema multiforme—Methotrexate—systemic lupus erythematosus	7.08e-05	0.000186	CcSEcCtD
Paroxetine—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	7.07e-05	0.000186	CcSEcCtD
Paroxetine—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	7.06e-05	0.000186	CcSEcCtD
Paroxetine—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	7.06e-05	0.000186	CcSEcCtD
Paroxetine—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	7.05e-05	0.000185	CcSEcCtD
Paroxetine—Malaise—Prednisone—systemic lupus erythematosus	7.03e-05	0.000185	CcSEcCtD
Paroxetine—Vertigo—Prednisone—systemic lupus erythematosus	7.01e-05	0.000184	CcSEcCtD
Paroxetine—Eye disorder—Methotrexate—systemic lupus erythematosus	7e-05	0.000184	CcSEcCtD
Paroxetine—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	6.99e-05	0.000184	CcSEcCtD
Paroxetine—Syncope—Prednisone—systemic lupus erythematosus	6.99e-05	0.000184	CcSEcCtD
Paroxetine—Tinnitus—Methotrexate—systemic lupus erythematosus	6.98e-05	0.000183	CcSEcCtD
Paroxetine—Urticaria—Prednisolone—systemic lupus erythematosus	6.96e-05	0.000183	CcSEcCtD
Paroxetine—Cardiac disorder—Methotrexate—systemic lupus erythematosus	6.95e-05	0.000183	CcSEcCtD
Paroxetine—Fatigue—Triamcinolone—systemic lupus erythematosus	6.94e-05	0.000183	CcSEcCtD
Paroxetine—Fatigue—Methylprednisolone—systemic lupus erythematosus	6.93e-05	0.000182	CcSEcCtD
Paroxetine—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	6.92e-05	0.000182	CcSEcCtD
Paroxetine—Asthenia—Cyclosporine—systemic lupus erythematosus	6.91e-05	0.000182	CcSEcCtD
Paroxetine—Pain—Triamcinolone—systemic lupus erythematosus	6.89e-05	0.000181	CcSEcCtD
Paroxetine—Loss of consciousness—Prednisone—systemic lupus erythematosus	6.85e-05	0.00018	CcSEcCtD
Paroxetine—Hypotension—Dexamethasone—systemic lupus erythematosus	6.83e-05	0.000179	CcSEcCtD
Paroxetine—Hypotension—Betamethasone—systemic lupus erythematosus	6.83e-05	0.000179	CcSEcCtD
Paroxetine—Pruritus—Cyclosporine—systemic lupus erythematosus	6.81e-05	0.000179	CcSEcCtD
Paroxetine—Urticaria—Hydrocortisone—systemic lupus erythematosus	6.8e-05	0.000179	CcSEcCtD
Paroxetine—Angiopathy—Methotrexate—systemic lupus erythematosus	6.79e-05	0.000179	CcSEcCtD
Paroxetine—Immune system disorder—Methotrexate—systemic lupus erythematosus	6.76e-05	0.000178	CcSEcCtD
Paroxetine—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	6.76e-05	0.000178	CcSEcCtD
Paroxetine—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	6.76e-05	0.000178	CcSEcCtD
Paroxetine—Convulsion—Prednisone—systemic lupus erythematosus	6.76e-05	0.000178	CcSEcCtD
Paroxetine—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	6.75e-05	0.000177	CcSEcCtD
Paroxetine—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	6.74e-05	0.000177	CcSEcCtD
Paroxetine—Hypertension—Prednisone—systemic lupus erythematosus	6.73e-05	0.000177	CcSEcCtD
Paroxetine—Chills—Methotrexate—systemic lupus erythematosus	6.72e-05	0.000177	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	6.66e-05	0.000175	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	6.66e-05	0.000175	CcSEcCtD
Paroxetine—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	6.64e-05	0.000175	CcSEcCtD
Paroxetine—Myalgia—Prednisone—systemic lupus erythematosus	6.64e-05	0.000175	CcSEcCtD
Paroxetine—Arthralgia—Prednisone—systemic lupus erythematosus	6.64e-05	0.000175	CcSEcCtD
Paroxetine—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	6.64e-05	0.000174	CcSEcCtD
Paroxetine—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	6.62e-05	0.000174	CcSEcCtD
Paroxetine—Anxiety—Prednisone—systemic lupus erythematosus	6.62e-05	0.000174	CcSEcCtD
Paroxetine—Alopecia—Methotrexate—systemic lupus erythematosus	6.62e-05	0.000174	CcSEcCtD
Paroxetine—Insomnia—Betamethasone—systemic lupus erythematosus	6.61e-05	0.000174	CcSEcCtD
Paroxetine—Insomnia—Dexamethasone—systemic lupus erythematosus	6.61e-05	0.000174	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	6.59e-05	0.000173	CcSEcCtD
Paroxetine—Diarrhoea—Cyclosporine—systemic lupus erythematosus	6.59e-05	0.000173	CcSEcCtD
Paroxetine—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	6.57e-05	0.000173	CcSEcCtD
Paroxetine—Paraesthesia—Betamethasone—systemic lupus erythematosus	6.56e-05	0.000172	CcSEcCtD
Paroxetine—Paraesthesia—Dexamethasone—systemic lupus erythematosus	6.56e-05	0.000172	CcSEcCtD
Paroxetine—Discomfort—Prednisone—systemic lupus erythematosus	6.56e-05	0.000172	CcSEcCtD
Paroxetine—Mental disorder—Methotrexate—systemic lupus erythematosus	6.56e-05	0.000172	CcSEcCtD
Paroxetine—Malnutrition—Methotrexate—systemic lupus erythematosus	6.52e-05	0.000171	CcSEcCtD
Paroxetine—Erythema—Methotrexate—systemic lupus erythematosus	6.52e-05	0.000171	CcSEcCtD
Paroxetine—Hypersensitivity—Prednisolone—systemic lupus erythematosus	6.45e-05	0.00017	CcSEcCtD
Paroxetine—Dyspepsia—Dexamethasone—systemic lupus erythematosus	6.43e-05	0.000169	CcSEcCtD
Paroxetine—Dyspepsia—Betamethasone—systemic lupus erythematosus	6.43e-05	0.000169	CcSEcCtD
Paroxetine—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	6.42e-05	0.000169	CcSEcCtD
Paroxetine—Urticaria—Triamcinolone—systemic lupus erythematosus	6.4e-05	0.000168	CcSEcCtD
Paroxetine—Urticaria—Methylprednisolone—systemic lupus erythematosus	6.38e-05	0.000168	CcSEcCtD
Paroxetine—Dysgeusia—Methotrexate—systemic lupus erythematosus	6.38e-05	0.000168	CcSEcCtD
Paroxetine—Body temperature increased—Triamcinolone—systemic lupus erythematosus	6.37e-05	0.000167	CcSEcCtD
Paroxetine—Dizziness—Cyclosporine—systemic lupus erythematosus	6.36e-05	0.000167	CcSEcCtD
Paroxetine—Anaphylactic shock—Prednisone—systemic lupus erythematosus	6.36e-05	0.000167	CcSEcCtD
Paroxetine—Oedema—Prednisone—systemic lupus erythematosus	6.36e-05	0.000167	CcSEcCtD
Paroxetine—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	6.35e-05	0.000167	CcSEcCtD
Paroxetine—Decreased appetite—Dexamethasone—systemic lupus erythematosus	6.35e-05	0.000167	CcSEcCtD
Paroxetine—Decreased appetite—Betamethasone—systemic lupus erythematosus	6.35e-05	0.000167	CcSEcCtD
Paroxetine—Infection—Prednisone—systemic lupus erythematosus	6.32e-05	0.000166	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	6.31e-05	0.000166	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	6.31e-05	0.000166	CcSEcCtD
Paroxetine—Back pain—Methotrexate—systemic lupus erythematosus	6.3e-05	0.000166	CcSEcCtD
Paroxetine—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	6.3e-05	0.000166	CcSEcCtD
Paroxetine—Fatigue—Dexamethasone—systemic lupus erythematosus	6.3e-05	0.000166	CcSEcCtD
Paroxetine—Fatigue—Betamethasone—systemic lupus erythematosus	6.3e-05	0.000166	CcSEcCtD
Paroxetine—Shock—Prednisone—systemic lupus erythematosus	6.26e-05	0.000165	CcSEcCtD
Paroxetine—Pain—Betamethasone—systemic lupus erythematosus	6.25e-05	0.000164	CcSEcCtD
Paroxetine—Pain—Dexamethasone—systemic lupus erythematosus	6.25e-05	0.000164	CcSEcCtD
Paroxetine—Nervous system disorder—Prednisone—systemic lupus erythematosus	6.24e-05	0.000164	CcSEcCtD
Paroxetine—Tachycardia—Prednisone—systemic lupus erythematosus	6.21e-05	0.000163	CcSEcCtD
Paroxetine—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	6.21e-05	0.000163	CcSEcCtD
Paroxetine—Skin disorder—Prednisone—systemic lupus erythematosus	6.18e-05	0.000162	CcSEcCtD
Paroxetine—Hyperhidrosis—Prednisone—systemic lupus erythematosus	6.15e-05	0.000162	CcSEcCtD
Paroxetine—Vision blurred—Methotrexate—systemic lupus erythematosus	6.14e-05	0.000161	CcSEcCtD
Paroxetine—Asthenia—Hydrocortisone—systemic lupus erythematosus	6.14e-05	0.000161	CcSEcCtD
Paroxetine—Vomiting—Cyclosporine—systemic lupus erythematosus	6.12e-05	0.000161	CcSEcCtD
Paroxetine—Rash—Cyclosporine—systemic lupus erythematosus	6.07e-05	0.00016	CcSEcCtD
Paroxetine—Dermatitis—Cyclosporine—systemic lupus erythematosus	6.06e-05	0.000159	CcSEcCtD
Paroxetine—Pruritus—Hydrocortisone—systemic lupus erythematosus	6.05e-05	0.000159	CcSEcCtD
Paroxetine—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	6.05e-05	0.000159	CcSEcCtD
Paroxetine—Headache—Cyclosporine—systemic lupus erythematosus	6.03e-05	0.000158	CcSEcCtD
Paroxetine—Anaemia—Methotrexate—systemic lupus erythematosus	6.02e-05	0.000158	CcSEcCtD
Paroxetine—Feeling abnormal—Betamethasone—systemic lupus erythematosus	6.02e-05	0.000158	CcSEcCtD
Paroxetine—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	6.02e-05	0.000158	CcSEcCtD
Paroxetine—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	5.98e-05	0.000157	CcSEcCtD
Paroxetine—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	5.98e-05	0.000157	CcSEcCtD
Paroxetine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	5.97e-05	0.000157	CcSEcCtD
Paroxetine—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	5.93e-05	0.000156	CcSEcCtD
Paroxetine—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	5.92e-05	0.000156	CcSEcCtD
Paroxetine—Rash—Mycophenolate mofetil—systemic lupus erythematosus	5.92e-05	0.000156	CcSEcCtD
Paroxetine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	5.91e-05	0.000155	CcSEcCtD
Paroxetine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	5.88e-05	0.000155	CcSEcCtD
Paroxetine—Malaise—Methotrexate—systemic lupus erythematosus	5.88e-05	0.000154	CcSEcCtD
Paroxetine—Vertigo—Methotrexate—systemic lupus erythematosus	5.86e-05	0.000154	CcSEcCtD
Paroxetine—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	5.85e-05	0.000154	CcSEcCtD
Paroxetine—Leukopenia—Methotrexate—systemic lupus erythematosus	5.83e-05	0.000153	CcSEcCtD
Paroxetine—Urticaria—Betamethasone—systemic lupus erythematosus	5.81e-05	0.000153	CcSEcCtD
Paroxetine—Urticaria—Dexamethasone—systemic lupus erythematosus	5.81e-05	0.000153	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	5.8e-05	0.000152	CcSEcCtD
Paroxetine—Dizziness—Prednisolone—systemic lupus erythematosus	5.79e-05	0.000152	CcSEcCtD
Paroxetine—Asthenia—Triamcinolone—systemic lupus erythematosus	5.78e-05	0.000152	CcSEcCtD
Paroxetine—Abdominal pain—Betamethasone—systemic lupus erythematosus	5.78e-05	0.000152	CcSEcCtD
Paroxetine—Abdominal pain—Dexamethasone—systemic lupus erythematosus	5.78e-05	0.000152	CcSEcCtD
Paroxetine—Body temperature increased—Dexamethasone—systemic lupus erythematosus	5.78e-05	0.000152	CcSEcCtD
Paroxetine—Body temperature increased—Betamethasone—systemic lupus erythematosus	5.78e-05	0.000152	CcSEcCtD
Paroxetine—Asthenia—Methylprednisolone—systemic lupus erythematosus	5.77e-05	0.000152	CcSEcCtD
Paroxetine—Insomnia—Prednisone—systemic lupus erythematosus	5.76e-05	0.000151	CcSEcCtD
Paroxetine—Nausea—Cyclosporine—systemic lupus erythematosus	5.72e-05	0.00015	CcSEcCtD
Paroxetine—Paraesthesia—Prednisone—systemic lupus erythematosus	5.71e-05	0.00015	CcSEcCtD
Paroxetine—Pruritus—Triamcinolone—systemic lupus erythematosus	5.7e-05	0.00015	CcSEcCtD
Paroxetine—Cough—Methotrexate—systemic lupus erythematosus	5.69e-05	0.000149	CcSEcCtD
Paroxetine—Pruritus—Methylprednisolone—systemic lupus erythematosus	5.69e-05	0.000149	CcSEcCtD
Paroxetine—Dizziness—Hydrocortisone—systemic lupus erythematosus	5.66e-05	0.000149	CcSEcCtD
Paroxetine—Convulsion—Methotrexate—systemic lupus erythematosus	5.65e-05	0.000148	CcSEcCtD
Paroxetine—Dyspepsia—Prednisone—systemic lupus erythematosus	5.6e-05	0.000147	CcSEcCtD
Paroxetine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	5.58e-05	0.000147	CcSEcCtD
Paroxetine—Arthralgia—Methotrexate—systemic lupus erythematosus	5.55e-05	0.000146	CcSEcCtD
Paroxetine—Myalgia—Methotrexate—systemic lupus erythematosus	5.55e-05	0.000146	CcSEcCtD
Paroxetine—Chest pain—Methotrexate—systemic lupus erythematosus	5.55e-05	0.000146	CcSEcCtD
Paroxetine—Decreased appetite—Prednisone—systemic lupus erythematosus	5.53e-05	0.000145	CcSEcCtD
Paroxetine—Rash—Prednisolone—systemic lupus erythematosus	5.52e-05	0.000145	CcSEcCtD
Paroxetine—Dermatitis—Prednisolone—systemic lupus erythematosus	5.52e-05	0.000145	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	5.51e-05	0.000145	CcSEcCtD
Paroxetine—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	5.5e-05	0.000145	CcSEcCtD
Paroxetine—Fatigue—Prednisone—systemic lupus erythematosus	5.49e-05	0.000144	CcSEcCtD
Paroxetine—Headache—Prednisolone—systemic lupus erythematosus	5.49e-05	0.000144	CcSEcCtD
Paroxetine—Discomfort—Methotrexate—systemic lupus erythematosus	5.48e-05	0.000144	CcSEcCtD
Paroxetine—Constipation—Prednisone—systemic lupus erythematosus	5.44e-05	0.000143	CcSEcCtD
Paroxetine—Vomiting—Hydrocortisone—systemic lupus erythematosus	5.44e-05	0.000143	CcSEcCtD
Paroxetine—Rash—Hydrocortisone—systemic lupus erythematosus	5.39e-05	0.000142	CcSEcCtD
Paroxetine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	5.39e-05	0.000142	CcSEcCtD
Paroxetine—Confusional state—Methotrexate—systemic lupus erythematosus	5.36e-05	0.000141	CcSEcCtD
Paroxetine—Headache—Hydrocortisone—systemic lupus erythematosus	5.36e-05	0.000141	CcSEcCtD
Paroxetine—Dizziness—Triamcinolone—systemic lupus erythematosus	5.33e-05	0.00014	CcSEcCtD
Paroxetine—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	5.32e-05	0.00014	CcSEcCtD
Paroxetine—Dizziness—Methylprednisolone—systemic lupus erythematosus	5.31e-05	0.00014	CcSEcCtD
Paroxetine—Infection—Methotrexate—systemic lupus erythematosus	5.28e-05	0.000139	CcSEcCtD
Paroxetine—Feeling abnormal—Prednisone—systemic lupus erythematosus	5.24e-05	0.000138	CcSEcCtD
Paroxetine—Asthenia—Dexamethasone—systemic lupus erythematosus	5.24e-05	0.000138	CcSEcCtD
Paroxetine—Asthenia—Betamethasone—systemic lupus erythematosus	5.24e-05	0.000138	CcSEcCtD
Paroxetine—Nervous system disorder—Methotrexate—systemic lupus erythematosus	5.22e-05	0.000137	CcSEcCtD
Paroxetine—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	5.21e-05	0.000137	CcSEcCtD
Paroxetine—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	5.2e-05	0.000137	CcSEcCtD
Paroxetine—Nausea—Prednisolone—systemic lupus erythematosus	5.2e-05	0.000137	CcSEcCtD
Paroxetine—Pruritus—Dexamethasone—systemic lupus erythematosus	5.17e-05	0.000136	CcSEcCtD
Paroxetine—Pruritus—Betamethasone—systemic lupus erythematosus	5.17e-05	0.000136	CcSEcCtD
Paroxetine—Skin disorder—Methotrexate—systemic lupus erythematosus	5.17e-05	0.000136	CcSEcCtD
Paroxetine—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	5.14e-05	0.000135	CcSEcCtD
Paroxetine—Vomiting—Triamcinolone—systemic lupus erythematosus	5.12e-05	0.000135	CcSEcCtD
Paroxetine—Vomiting—Methylprednisolone—systemic lupus erythematosus	5.11e-05	0.000134	CcSEcCtD
Paroxetine—Nausea—Hydrocortisone—systemic lupus erythematosus	5.08e-05	0.000134	CcSEcCtD
Paroxetine—Rash—Triamcinolone—systemic lupus erythematosus	5.08e-05	0.000133	CcSEcCtD
Paroxetine—Dermatitis—Triamcinolone—systemic lupus erythematosus	5.07e-05	0.000133	CcSEcCtD
Paroxetine—Rash—Methylprednisolone—systemic lupus erythematosus	5.07e-05	0.000133	CcSEcCtD
Paroxetine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	5.06e-05	0.000133	CcSEcCtD
Paroxetine—Urticaria—Prednisone—systemic lupus erythematosus	5.06e-05	0.000133	CcSEcCtD
Paroxetine—Headache—Triamcinolone—systemic lupus erythematosus	5.05e-05	0.000133	CcSEcCtD
Paroxetine—Headache—Methylprednisolone—systemic lupus erythematosus	5.03e-05	0.000132	CcSEcCtD
Paroxetine—Abdominal pain—Prednisone—systemic lupus erythematosus	5.03e-05	0.000132	CcSEcCtD
Paroxetine—Body temperature increased—Prednisone—systemic lupus erythematosus	5.03e-05	0.000132	CcSEcCtD
Paroxetine—Diarrhoea—Dexamethasone—systemic lupus erythematosus	5e-05	0.000131	CcSEcCtD
Paroxetine—Diarrhoea—Betamethasone—systemic lupus erythematosus	5e-05	0.000131	CcSEcCtD
Paroxetine—Hypotension—Methotrexate—systemic lupus erythematosus	4.97e-05	0.000131	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	4.85e-05	0.000127	CcSEcCtD
Paroxetine—Dizziness—Betamethasone—systemic lupus erythematosus	4.83e-05	0.000127	CcSEcCtD
Paroxetine—Dizziness—Dexamethasone—systemic lupus erythematosus	4.83e-05	0.000127	CcSEcCtD
Paroxetine—Insomnia—Methotrexate—systemic lupus erythematosus	4.81e-05	0.000126	CcSEcCtD
Paroxetine—Nausea—Triamcinolone—systemic lupus erythematosus	4.78e-05	0.000126	CcSEcCtD
Paroxetine—Paraesthesia—Methotrexate—systemic lupus erythematosus	4.78e-05	0.000126	CcSEcCtD
Paroxetine—Nausea—Methylprednisolone—systemic lupus erythematosus	4.77e-05	0.000125	CcSEcCtD
Paroxetine—Dyspnoea—Methotrexate—systemic lupus erythematosus	4.74e-05	0.000125	CcSEcCtD
Paroxetine—Somnolence—Methotrexate—systemic lupus erythematosus	4.73e-05	0.000124	CcSEcCtD
Paroxetine—Hypersensitivity—Prednisone—systemic lupus erythematosus	4.69e-05	0.000123	CcSEcCtD
Paroxetine—Dyspepsia—Methotrexate—systemic lupus erythematosus	4.68e-05	0.000123	CcSEcCtD
Paroxetine—Vomiting—Dexamethasone—systemic lupus erythematosus	4.65e-05	0.000122	CcSEcCtD
Paroxetine—Vomiting—Betamethasone—systemic lupus erythematosus	4.65e-05	0.000122	CcSEcCtD
Paroxetine—Decreased appetite—Methotrexate—systemic lupus erythematosus	4.62e-05	0.000122	CcSEcCtD
Paroxetine—Rash—Dexamethasone—systemic lupus erythematosus	4.61e-05	0.000121	CcSEcCtD
Paroxetine—Rash—Betamethasone—systemic lupus erythematosus	4.61e-05	0.000121	CcSEcCtD
Paroxetine—Dermatitis—Betamethasone—systemic lupus erythematosus	4.6e-05	0.000121	CcSEcCtD
Paroxetine—Dermatitis—Dexamethasone—systemic lupus erythematosus	4.6e-05	0.000121	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	4.59e-05	0.000121	CcSEcCtD
Paroxetine—Fatigue—Methotrexate—systemic lupus erythematosus	4.59e-05	0.000121	CcSEcCtD
Paroxetine—Headache—Betamethasone—systemic lupus erythematosus	4.58e-05	0.00012	CcSEcCtD
Paroxetine—Headache—Dexamethasone—systemic lupus erythematosus	4.58e-05	0.00012	CcSEcCtD
Paroxetine—Asthenia—Prednisone—systemic lupus erythematosus	4.57e-05	0.00012	CcSEcCtD
Paroxetine—Pain—Methotrexate—systemic lupus erythematosus	4.55e-05	0.00012	CcSEcCtD
Paroxetine—Pruritus—Prednisone—systemic lupus erythematosus	4.5e-05	0.000118	CcSEcCtD
Paroxetine—Feeling abnormal—Methotrexate—systemic lupus erythematosus	4.38e-05	0.000115	CcSEcCtD
Paroxetine—Diarrhoea—Prednisone—systemic lupus erythematosus	4.35e-05	0.000114	CcSEcCtD
Paroxetine—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	4.35e-05	0.000114	CcSEcCtD
Paroxetine—Nausea—Dexamethasone—systemic lupus erythematosus	4.34e-05	0.000114	CcSEcCtD
Paroxetine—Nausea—Betamethasone—systemic lupus erythematosus	4.34e-05	0.000114	CcSEcCtD
Paroxetine—Urticaria—Methotrexate—systemic lupus erythematosus	4.23e-05	0.000111	CcSEcCtD
Paroxetine—Dizziness—Prednisone—systemic lupus erythematosus	4.21e-05	0.000111	CcSEcCtD
Paroxetine—Abdominal pain—Methotrexate—systemic lupus erythematosus	4.2e-05	0.000111	CcSEcCtD
Paroxetine—Body temperature increased—Methotrexate—systemic lupus erythematosus	4.2e-05	0.000111	CcSEcCtD
Paroxetine—Vomiting—Prednisone—systemic lupus erythematosus	4.05e-05	0.000106	CcSEcCtD
Paroxetine—Rash—Prednisone—systemic lupus erythematosus	4.01e-05	0.000105	CcSEcCtD
Paroxetine—Dermatitis—Prednisone—systemic lupus erythematosus	4.01e-05	0.000105	CcSEcCtD
Paroxetine—Headache—Prednisone—systemic lupus erythematosus	3.99e-05	0.000105	CcSEcCtD
Paroxetine—Hypersensitivity—Methotrexate—systemic lupus erythematosus	3.92e-05	0.000103	CcSEcCtD
Paroxetine—Asthenia—Methotrexate—systemic lupus erythematosus	3.82e-05	0.0001	CcSEcCtD
Paroxetine—Nausea—Prednisone—systemic lupus erythematosus	3.78e-05	9.94e-05	CcSEcCtD
Paroxetine—Pruritus—Methotrexate—systemic lupus erythematosus	3.76e-05	9.89e-05	CcSEcCtD
Paroxetine—Diarrhoea—Methotrexate—systemic lupus erythematosus	3.64e-05	9.57e-05	CcSEcCtD
Paroxetine—Dizziness—Methotrexate—systemic lupus erythematosus	3.52e-05	9.25e-05	CcSEcCtD
Paroxetine—Vomiting—Methotrexate—systemic lupus erythematosus	3.38e-05	8.89e-05	CcSEcCtD
Paroxetine—Rash—Methotrexate—systemic lupus erythematosus	3.35e-05	8.82e-05	CcSEcCtD
Paroxetine—Dermatitis—Methotrexate—systemic lupus erythematosus	3.35e-05	8.81e-05	CcSEcCtD
Paroxetine—Headache—Methotrexate—systemic lupus erythematosus	3.33e-05	8.76e-05	CcSEcCtD
Paroxetine—Nausea—Methotrexate—systemic lupus erythematosus	3.16e-05	8.3e-05	CcSEcCtD
Paroxetine—CHRM3—GPCR downstream signaling—CCR5—systemic lupus erythematosus	1.18e-05	0.000378	CbGpPWpGaD
Paroxetine—TACR1—Signaling by GPCR—IL6—systemic lupus erythematosus	1.18e-05	0.000378	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	1.18e-05	0.000376	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—CCR5—systemic lupus erythematosus	1.17e-05	0.000374	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—CCL2—systemic lupus erythematosus	1.17e-05	0.000374	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	1.17e-05	0.000374	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NCF2—systemic lupus erythematosus	1.17e-05	0.000373	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.17e-05	0.000373	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—C3—systemic lupus erythematosus	1.17e-05	0.000372	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	1.17e-05	0.000372	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NCF2—systemic lupus erythematosus	1.16e-05	0.000371	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—LYN—systemic lupus erythematosus	1.16e-05	0.000371	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—C3—systemic lupus erythematosus	1.16e-05	0.00037	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NCF2—systemic lupus erythematosus	1.16e-05	0.00037	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—C3—systemic lupus erythematosus	1.16e-05	0.000369	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	1.16e-05	0.000369	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—LYN—systemic lupus erythematosus	1.16e-05	0.000369	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—LYN—systemic lupus erythematosus	1.15e-05	0.000368	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NCF2—systemic lupus erythematosus	1.15e-05	0.000366	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—C3—systemic lupus erythematosus	1.15e-05	0.000366	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—JAK1—systemic lupus erythematosus	1.14e-05	0.000365	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—LYN—systemic lupus erythematosus	1.14e-05	0.000364	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.14e-05	0.000364	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—JAK1—systemic lupus erythematosus	1.14e-05	0.000363	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—JAK1—systemic lupus erythematosus	1.13e-05	0.000362	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.13e-05	0.000362	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.13e-05	0.000361	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.13e-05	0.000359	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—JAK1—systemic lupus erythematosus	1.12e-05	0.000359	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.12e-05	0.000358	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.12e-05	0.000357	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.11e-05	0.000355	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.09e-05	0.000348	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—CCR5—systemic lupus erythematosus	1.08e-05	0.000346	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	1.08e-05	0.000344	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—CCR5—systemic lupus erythematosus	1.08e-05	0.000344	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—CCR5—systemic lupus erythematosus	1.08e-05	0.000343	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	1.07e-05	0.000341	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—EP300—systemic lupus erythematosus	1.07e-05	0.000341	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—CCR5—systemic lupus erythematosus	1.06e-05	0.00034	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.06e-05	0.00034	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	1.06e-05	0.000339	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—C3—systemic lupus erythematosus	1.06e-05	0.000338	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL2RA—systemic lupus erythematosus	1.06e-05	0.000338	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—C3—systemic lupus erythematosus	1.05e-05	0.000336	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—C3—systemic lupus erythematosus	1.05e-05	0.000335	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL2RA—systemic lupus erythematosus	1.05e-05	0.000335	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—C3—systemic lupus erythematosus	1.04e-05	0.000332	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—F2—systemic lupus erythematosus	1.02e-05	0.000327	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—F2—systemic lupus erythematosus	1.02e-05	0.000325	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.02e-05	0.000325	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	1.02e-05	0.000325	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—F2—systemic lupus erythematosus	1.02e-05	0.000324	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.01e-05	0.000323	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	1.01e-05	0.000322	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—F2—systemic lupus erythematosus	1.01e-05	0.000321	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—JAK1—systemic lupus erythematosus	9.97e-06	0.000318	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	9.84e-06	0.000314	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—IL2—systemic lupus erythematosus	9.75e-06	0.000311	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—JAK1—systemic lupus erythematosus	9.55e-06	0.000305	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—RXRA—systemic lupus erythematosus	9.53e-06	0.000304	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CCR5—systemic lupus erythematosus	9.45e-06	0.000302	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CXCL12—systemic lupus erythematosus	9.35e-06	0.000298	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL2RA—systemic lupus erythematosus	9.31e-06	0.000297	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—F2—systemic lupus erythematosus	9.3e-06	0.000297	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CXCL12—systemic lupus erythematosus	9.3e-06	0.000297	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.28e-06	0.000296	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CXCL12—systemic lupus erythematosus	9.27e-06	0.000296	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—F2—systemic lupus erythematosus	9.25e-06	0.000295	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—IL2—systemic lupus erythematosus	9.24e-06	0.000295	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—C3—systemic lupus erythematosus	9.24e-06	0.000295	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—F2—systemic lupus erythematosus	9.23e-06	0.000294	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CXCL12—systemic lupus erythematosus	9.18e-06	0.000293	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—JUNB—systemic lupus erythematosus	9.18e-06	0.000293	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—F2—systemic lupus erythematosus	9.14e-06	0.000292	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—JUNB—systemic lupus erythematosus	9.13e-06	0.000291	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—JUNB—systemic lupus erythematosus	9.1e-06	0.00029	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CCR5—systemic lupus erythematosus	9.05e-06	0.000289	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—JUNB—systemic lupus erythematosus	9.01e-06	0.000288	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL2RA—systemic lupus erythematosus	8.92e-06	0.000285	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	8.85e-06	0.000283	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—IL2—systemic lupus erythematosus	8.85e-06	0.000283	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—C3—systemic lupus erythematosus	8.84e-06	0.000282	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.72e-06	0.000278	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.67e-06	0.000277	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.64e-06	0.000276	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.56e-06	0.000273	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PRL—systemic lupus erythematosus	8.45e-06	0.00027	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PRL—systemic lupus erythematosus	8.41e-06	0.000268	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PRL—systemic lupus erythematosus	8.38e-06	0.000267	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PRL—systemic lupus erythematosus	8.3e-06	0.000265	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—CCL2—systemic lupus erythematosus	8.29e-06	0.000265	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—CCL2—systemic lupus erythematosus	8.25e-06	0.000263	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—CCL2—systemic lupus erythematosus	8.22e-06	0.000262	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—RXRA—systemic lupus erythematosus	8.2e-06	0.000262	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—CCL2—systemic lupus erythematosus	8.14e-06	0.00026	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—F2—systemic lupus erythematosus	8.11e-06	0.000259	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	8.01e-06	0.000256	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CD80—systemic lupus erythematosus	7.77e-06	0.000248	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—F2—systemic lupus erythematosus	7.76e-06	0.000248	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	7.74e-06	0.000247	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—TYK2—systemic lupus erythematosus	7.53e-06	0.00024	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—TYK2—systemic lupus erythematosus	7.49e-06	0.000239	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—TYK2—systemic lupus erythematosus	7.47e-06	0.000238	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CD80—systemic lupus erythematosus	7.44e-06	0.000238	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—TYK2—systemic lupus erythematosus	7.39e-06	0.000236	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	7.33e-06	0.000234	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CCL2—systemic lupus erythematosus	7.23e-06	0.000231	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	7.2e-06	0.00023	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—IL6—systemic lupus erythematosus	6.99e-06	0.000223	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	6.94e-06	0.000222	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CCL2—systemic lupus erythematosus	6.92e-06	0.000221	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—IL2—systemic lupus erythematosus	6.9e-06	0.00022	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—IL2—systemic lupus erythematosus	6.86e-06	0.000219	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—IL2—systemic lupus erythematosus	6.84e-06	0.000218	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—IL2—systemic lupus erythematosus	6.78e-06	0.000216	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—JAK1—systemic lupus erythematosus	6.76e-06	0.000216	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—JAK1—systemic lupus erythematosus	6.72e-06	0.000215	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—JAK1—systemic lupus erythematosus	6.7e-06	0.000214	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—JAK1—systemic lupus erythematosus	6.64e-06	0.000212	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TYK2—systemic lupus erythematosus	6.56e-06	0.000209	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—NOS3—systemic lupus erythematosus	6.44e-06	0.000206	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	6.44e-06	0.000206	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCR5—systemic lupus erythematosus	6.41e-06	0.000204	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCR5—systemic lupus erythematosus	6.37e-06	0.000203	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCR5—systemic lupus erythematosus	6.35e-06	0.000203	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.31e-06	0.000202	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	6.3e-06	0.000201	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCR5—systemic lupus erythematosus	6.29e-06	0.000201	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TYK2—systemic lupus erythematosus	6.28e-06	0.000201	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.28e-06	0.0002	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL2—systemic lupus erythematosus	6.27e-06	0.0002	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—C3—systemic lupus erythematosus	6.26e-06	0.0002	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.26e-06	0.0002	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL2—systemic lupus erythematosus	6.23e-06	0.000199	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—C3—systemic lupus erythematosus	6.23e-06	0.000199	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL2—systemic lupus erythematosus	6.21e-06	0.000198	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—C3—systemic lupus erythematosus	6.21e-06	0.000198	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.2e-06	0.000198	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—NOS3—systemic lupus erythematosus	6.17e-06	0.000197	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL2—systemic lupus erythematosus	6.15e-06	0.000196	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—C3—systemic lupus erythematosus	6.15e-06	0.000196	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	6.05e-06	0.000193	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PPARG—systemic lupus erythematosus	6.02e-06	0.000192	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	5.7e-06	0.000182	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	5.65e-06	0.00018	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.58e-06	0.000178	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—F2—systemic lupus erythematosus	5.5e-06	0.000175	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—F2—systemic lupus erythematosus	5.47e-06	0.000174	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL2—systemic lupus erythematosus	5.46e-06	0.000174	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—F2—systemic lupus erythematosus	5.45e-06	0.000174	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—IL6—systemic lupus erythematosus	5.43e-06	0.000173	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—ALB—systemic lupus erythematosus	5.41e-06	0.000173	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—F2—systemic lupus erythematosus	5.4e-06	0.000172	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.34e-06	0.000171	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CD80—systemic lupus erythematosus	5.27e-06	0.000168	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.24e-06	0.000167	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CD80—systemic lupus erythematosus	5.24e-06	0.000167	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL2—systemic lupus erythematosus	5.23e-06	0.000167	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CD80—systemic lupus erythematosus	5.22e-06	0.000167	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—IL6—systemic lupus erythematosus	5.2e-06	0.000166	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PPARG—systemic lupus erythematosus	5.18e-06	0.000165	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—NOS3—systemic lupus erythematosus	5.18e-06	0.000165	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CD80—systemic lupus erythematosus	5.17e-06	0.000165	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—MMP9—systemic lupus erythematosus	5.17e-06	0.000165	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.15e-06	0.000164	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—MMP9—systemic lupus erythematosus	4.95e-06	0.000158	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.93e-06	0.000157	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—EP300—systemic lupus erythematosus	4.9e-06	0.000156	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCL2—systemic lupus erythematosus	4.9e-06	0.000156	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCL2—systemic lupus erythematosus	4.87e-06	0.000156	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCL2—systemic lupus erythematosus	4.86e-06	0.000155	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCL2—systemic lupus erythematosus	4.81e-06	0.000154	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PTGS2—systemic lupus erythematosus	4.74e-06	0.000151	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—EP300—systemic lupus erythematosus	4.69e-06	0.00015	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—ALB—systemic lupus erythematosus	4.66e-06	0.000149	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.64e-06	0.000148	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—NOS3—systemic lupus erythematosus	4.45e-06	0.000142	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TYK2—systemic lupus erythematosus	4.45e-06	0.000142	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.44e-06	0.000142	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TYK2—systemic lupus erythematosus	4.42e-06	0.000141	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TYK2—systemic lupus erythematosus	4.41e-06	0.000141	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	4.38e-06	0.00014	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TYK2—systemic lupus erythematosus	4.37e-06	0.000139	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NOS3—systemic lupus erythematosus	4.37e-06	0.000139	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NOS3—systemic lupus erythematosus	4.34e-06	0.000139	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NOS3—systemic lupus erythematosus	4.33e-06	0.000138	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NOS3—systemic lupus erythematosus	4.29e-06	0.000137	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.26e-06	0.000136	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.08e-06	0.00013	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PTGS2—systemic lupus erythematosus	4.07e-06	0.00013	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	3.94e-06	0.000126	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—EP300—systemic lupus erythematosus	3.94e-06	0.000126	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	3.82e-06	0.000122	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.78e-06	0.000121	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	3.77e-06	0.00012	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.76e-06	0.00012	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.75e-06	0.00012	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.71e-06	0.000119	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL2—systemic lupus erythematosus	3.7e-06	0.000118	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL6—systemic lupus erythematosus	3.68e-06	0.000118	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL2—systemic lupus erythematosus	3.68e-06	0.000118	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL2—systemic lupus erythematosus	3.67e-06	0.000117	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL6—systemic lupus erythematosus	3.66e-06	0.000117	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL6—systemic lupus erythematosus	3.65e-06	0.000117	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL2—systemic lupus erythematosus	3.63e-06	0.000116	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL6—systemic lupus erythematosus	3.62e-06	0.000115	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	3.6e-06	0.000115	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	3.57e-06	0.000114	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MMP9—systemic lupus erythematosus	3.5e-06	0.000112	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.49e-06	0.000111	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MMP9—systemic lupus erythematosus	3.48e-06	0.000111	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MMP9—systemic lupus erythematosus	3.47e-06	0.000111	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.47e-06	0.000111	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.46e-06	0.00011	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	3.45e-06	0.00011	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MMP9—systemic lupus erythematosus	3.44e-06	0.00011	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ALB—systemic lupus erythematosus	3.43e-06	0.00011	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.43e-06	0.000109	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—EP300—systemic lupus erythematosus	3.39e-06	0.000108	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—EP300—systemic lupus erythematosus	3.32e-06	0.000106	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—EP300—systemic lupus erythematosus	3.3e-06	0.000105	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—EP300—systemic lupus erythematosus	3.29e-06	0.000105	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	3.29e-06	0.000105	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—EP300—systemic lupus erythematosus	3.26e-06	0.000104	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	3.24e-06	0.000103	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL6—systemic lupus erythematosus	3.21e-06	0.000102	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	3.21e-06	0.000102	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.15e-06	0.0001	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.13e-06	9.99e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.12e-06	9.95e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	3.1e-06	9.88e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.09e-06	9.86e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL6—systemic lupus erythematosus	3.07e-06	9.81e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	3.07e-06	9.79e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	3e-06	9.59e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.89e-06	9.22e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.87e-06	9.17e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	2.87e-06	9.15e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.86e-06	9.14e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.83e-06	9.05e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	2.83e-06	9.04e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	2.81e-06	8.96e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—EP300—systemic lupus erythematosus	2.5e-06	7.98e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	2.35e-06	7.52e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	2.33e-06	7.45e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL6—systemic lupus erythematosus	2.18e-06	6.94e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL6—systemic lupus erythematosus	2.16e-06	6.91e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL6—systemic lupus erythematosus	2.16e-06	6.88e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL6—systemic lupus erythematosus	2.14e-06	6.82e-05	CbGpPWpGaD
